Depleting intestinal fungi allows radiation to effectively fight cancer, likely because the microbes influence the antitumor immune response.

New experiments suggest the famous tumor-suppressing protein uses viral elements lingering in the genome to get cancerous cells to announce their presence to the immune system.

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

A look at the molecular processes that may feed into the tumor-fighting effects of physical activity

Gene editing can knock out genes crucial to cervical tumor cells’ survival, researchers report.

Studies point to a role for physical activity in fighting malignancies, improving treatment outcomes, and fostering overall health in patients.

Researchers use a new way to deliver CRISPR/Cas9 to tumors in mice, wiping out the cancer.

Researchers use 3-D printing technology to construct a brain cancer model that accurately recapitulated in vivo biology and predicted patient drug responses.

How researchers create a glioblastoma on a chip that can predict patients’ response to treatments

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

Researchers plan to turn cancer cells into defectors, engineering them to kill the tumors from whence they came, and have tested the approach in mice.

More than one-fifth of individuals treated with the genetically modified virus survived at least three years.